Traditem

Traditem was a French specialty pharmaceutical company based in Boulogne-Billancourt that focused on the market access, distribution, and commercialization of orphan drugs and specialty therapeutics for rare diseases. The company operated as a "Laboratoire Exploitant," providing the necessary regulatory and medical infrastructure for international biotechnology firms to launch and manage innovative treatments within the French healthcare system. Traditem was most notably recognized for its strategic partnership with Horizon Therapeutics, where it managed the distribution and market entry of ammonia-scavenging therapies such as Ravicti and Ammonaps for patients with urea cycle disorders. In 2020, the company's activities and expertise were effectively integrated into Horizon Therapeutics France (now part of Amgen) as the latter established its direct presence in the region.